Drug Evaluation Research
SJR0.138
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.138 | Q4 | 13.3% | |
| 2024 | — | — | 0.130 | Q4 | 14.0% | |
| 2023 | — | — | 0.138 | Q4 | 22.5% | |
| 2022 | — | — | 0.114 | Q4 | 19.0% | |
| 2021 | — | — | — | 7.7% | ||
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
1674-6376
region
Asiatic Region
coverage
2019-2026